Transient receptor potential ankyrin 1 contributes to the lysophosphatidylcholine-induced oxidative stress and cytotoxicity in OLN-93 oligodendrocyte

Andersson, 2008, Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress, J Neurosci, 28, 2485, 10.1523/JNEUROSCI.5369-07.2008

Angelova, 2018, Role of mitochondrial ROS in the brain: from physiology to neurodegeneration, FEBS Lett, 592, 692, 10.1002/1873-3468.12964

Askari, 2019, Promising neuroprotective effects of beta-caryophyllene against LPS-induced oligodendrocyte toxicity: a mechanistic study, Biochem Pharmacol, 159, 154, 10.1016/j.bcp.2018.12.001

Barnett, 2004, Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion, Ann Neurol, 55, 458, 10.1002/ana.20016

Bolcskei, 2018, Behavioural alterations and morphological changes are attenuated by the lack of TRPA1 receptors in the cuprizone-induced demyelination model in mice, J Neuroimmunol, 320, 1, 10.1016/j.jneuroim.2018.03.020

Brand, 2010, Membrane lipid modification by polyunsaturated fatty acids sensitizes oligodendroglial OLN-93 cells against oxidative stress and promotes up-regulation of heme oxygenase-1 (HSP32), J Neurochem, 113, 465, 10.1111/j.1471-4159.2010.06611.x

Campos-Mota, 2017, Role of ERK1/2 activation and nNOS uncoupling on endothelial dysfunction induced by lysophosphatidylcholine, Atherosclerosis, 258, 108, 10.1016/j.atherosclerosis.2016.11.022

Compston, 2008, Multiple sclerosis, Lancet, 372, 1502, 10.1016/S0140-6736(08)61620-7

Cossarizza, 1993, A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1), Biochem Biophys Res Commun, 197, 40, 10.1006/bbrc.1993.2438

Doihara, 2009, QGP-1 cells release 5-HT via TRPA1 activation: a model of human enterochromaffin cells, Mol Cell Biochem, 331, 239, 10.1007/s11010-009-0165-7

Fetisova, 2017, Mitochondria-targeted antioxidants as a prospective therapeutic strategy for multiple sclerosis, Curr Med Chem, 24, 2086, 10.2174/0929867324666170316114452

Freeman, 2017, NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes, J Exp Med, 214, 1351, 10.1084/jem.20150237

Fressinaud C, Vallat JM, Pouplard-Barthelaix A (1996) Platelet-derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin-like membranes repair in vitro. Glia 16:40–50. https://doi.org/10.1002/(sici)1098-1136(199601)16:1%3C40::aid-glia5%3E3.0.co;2-f

Gerstner, 2006, Maturation-dependent oligodendrocyte apoptosis caused by hyperoxia, J Neurosci Res, 84, 306, 10.1002/jnr.20880

Ghasemi, 2018, Nitric Oxide and mitochondrial function in neurological diseases, Neuroscience, 376, 48, 10.1016/j.neuroscience.2018.02.017

Guzik, 2003, Nitric oxide and superoxide in inflammation and immune regulation, J Physiol Pharmacol, 54, 469

Hamilton, 2016, Proton-gated Ca(2+)-permeable TRP channels damage myelin in conditions mimicking ischaemia, Nature, 529, 523, 10.1038/nature16519

Ignarro, 1999, Nitric oxide: a unique endogenous signaling molecule in vascular biology, Biosci Rep, 19, 51, 10.1023/A:1020150124721

Islam, 2017, Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders, Neurol Res, 39, 73, 10.1080/01616412.2016.1251711

Jarjour, 2012, In vitro modeling of central nervous system myelination and remyelination, Glia, 60, 1, 10.1002/glia.21231

Jeong, 2017, TRPM2 contributes to LPC-induced intracellular Ca2+ influx and microglial activation, Biochem Biophys Res Commun, 485, 301, 10.1016/j.bbrc.2017.02.087

Kalyvas, 2009, Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis, Brain, 132, 1221, 10.1093/brain/awp002

Kougias, 2006, Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis, Med Sci Monit, 12, Ra5

Lehnardt, 2002, The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS, J Neurosci, 22, 2478, 10.1523/JNEUROSCI.22-07-02478.2002

Li, 2017, TRP channel classification, Adv Exp Med Biol, 976, 1, 10.1007/978-94-024-1088-4_1

Li, 2016, Mitochondrial reactive oxygen species mediate lysophosphatidylcholine-induced endothelial cell activation, Arterioscler Thromb Vasc Biol, 36, 1090, 10.1161/ATVBAHA.115.306964

Liu, 2018, proBDNF inhibits the proliferation and migration of OLN93 oligodendrocytes, Mol Med Rep, 18, 3809

McKenzie, 2018, Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis, Proc Natl Acad Sci U S A, 115, E6065, 10.1073/pnas.1722041115

McNamara, 2007, TRPA1 mediates formalin-induced pain, Proc Natl Acad Sci U S A, 104, 13525, 10.1073/pnas.0705924104

Mihai, 2019, Computational Drug repurposing algorithm targeting TRPA1 calcium channel as a potential therapeutic solution for multiple sclerosis, Pharmaceutics, 11, 446, 10.3390/pharmaceutics11090446

Monet, 2009, Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation, Biochim Biophys Acta, 1793, 528, 10.1016/j.bbamcr.2009.01.003

Murakami, 2004, G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine, J Biol Chem, 279, 42484, 10.1074/jbc.M406561200

Nadjafi, 2015, Noscapine protects OLN-93 oligodendrocytes from ischemia-reperfusion damage: calcium and nitric oxide involvement, Acta Physiol Hung, 102, 351, 10.1556/036.102.2015.4.2

Pieragostino, 2015, An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis, Mol BioSyst, 11, 1563, 10.1039/C4MB00700J

Plemel, 2018, Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy, Glia, 66, 327, 10.1002/glia.23245

Saghy, 2016, TRPA1 deficiency is protective in cuprizone-induced demyelination—a new target against oligodendrocyte apoptosis, Glia, 64, 2166, 10.1002/glia.23051

Schilling, 2009, Non-selective cation channel activity is required for lysophosphatidylcholine-induced monocyte migration, J Cell Physiol, 221, 325, 10.1002/jcp.21857

Shi, 2017, Pyroptosis: gasdermin-mediated programmed necrotic cell death, Trends Biochem Sci, 42, 245, 10.1016/j.tibs.2016.10.004

Silva, 2018, Beneficial effects of the calcium channel blocker CTK 01512-2 in a mouse model of multiple sclerosis, Mol Neurobiol, 55, 9307, 10.1007/s12035-018-1049-1

Sinharoy, 2015, Propofol restores TRPV1 sensitivity via a TRPA1-, nitric oxide synthase-dependent activation of PKCepsilon, Pharmacol Res Perspect, 3, e00153, 10.1002/prp2.153

Soga, 2005, Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor, Biochem Biophys Res Commun, 326, 744, 10.1016/j.bbrc.2004.11.120

Strassmaier, 2011, Transient receptor potential A1 modulators, Curr Top Med Chem, 11, 2227, 10.2174/156802611796904915

Tian, 2020, Transient receptor potential ankyrin 1 contributes to lysophosphatidylcholine-induced intracellular calcium regulation and THP-1-derived macrophage activation, J Membr Biol, 253, 43, 10.1007/s00232-019-00104-2

Trapp, 2008, Multiple sclerosis: an immune or neurodegenerative disorder?, Annu Rev Neurosci, 31, 247, 10.1146/annurev.neuro.30.051606.094313

Wang, 2013, Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus, Pharmacol Biochem Behav, 106, 47, 10.1016/j.pbb.2013.03.002

Yao, 2010, LPS mediated injury to oligodendrocytes is mediated by the activation of nNOS: relevance to human demyelinating disease, Nitric Oxide, 22, 197, 10.1016/j.niox.2009.12.001

Yao, 2012, nNOS mediated mitochondrial injury in LPS stimulated oligodendrocytes, Mitochondrion, 12, 336, 10.1016/j.mito.2012.01.002